HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1786142Generated: October 30, 2026
3,4-Dichlorobenzaldehyde → HCID 135463472, compound
https://huagongshe.com/reaction/1786142
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 3,4-Dichlorobenzaldehyde | HCID 22710 | — |
| Reactant | HCID 57597021 | HCID 57597021 | — |
| Reactant | HCID 178418690 | HCID 178418690 | — |
| Catalyst | Piperidine | HCID 8082 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 135463472 | HCID 135463472 | — |
Reaction Steps
A mixture of 1-(pyrrolidin-1-ylsulfonyl)propan-2-one (191 mg, 1.0 mmol), 3,4-dichlorobenzaldehyde (175 mg, 1.0 mmol), 3-methyl-1H-pyrazol-5-amine (97 mg, 1.0 mmol), piperidine (2 drops) and Ti(OPr-i)4 (2 drops) in 1,4-dioxane (4.0 mL) in a sealed tube was stirred at 80° C. for 24 hrs. Solvent was removed and the residue was purified by flash chromatography (silica gel, 0% to 50% ethyl acetate in hexane gradient) to provide 7-(3,4-dichlorophenyl)-2,5-dimethyl-6-(pyrrolidin-1-ylsulfonyl)-4,7-dihydropyrazolo[1,5-a]pyrimidine as a white solid. LC-MS found: (M+1)+=427.10. The two enantiomers were separated with ChiralPAK AS using 20% EtOH-MeOH(1:1) in heptane as mobile phase.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07507730B2 |
|---|
| Source dataset | uspto-grants-2009_03 |
|---|
| ORD ID | ord-281e0b038bcd402b86969e2545e33af4 |
|---|
| Source note | uspto-grants-2009_03 |
|---|